List of Tables
Table 1. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Polyvalent Streptococcus Pneumococcal Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Polyvalent Streptococcus Pneumococcal Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polyvalent Streptococcus Pneumococcal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polyvalent Streptococcus Pneumococcal Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit) by Application (2026-2031)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 79. Merck Recent Developments/Updates
Table 80. Panacea Biotec Company Information
Table 81. Panacea Biotec Description and Business Overview
Table 82. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 84. Panacea Biotec Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Pnuvax Incorporated Company Information
Table 91. Pnuvax Incorporated Description and Business Overview
Table 92. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 94. Pnuvax Incorporated Recent Developments/Updates
Table 95. Serum Institute Company Information
Table 96. Serum Institute Description and Business Overview
Table 97. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 99. Serum Institute Recent Developments/Updates
Table 100. Shinogi Company Information
Table 101. Shinogi Description and Business Overview
Table 102. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 104. Shinogi Recent Developments/Updates
Table 105. Shenzhen Kangtai Biological Products Company Information
Table 106. Shenzhen Kangtai Biological Products Description and Business Overview
Table 107. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 109. Shenzhen Kangtai Biological Products Recent Developments/Updates
Table 110. SK Bioscience Company Information
Table 111. SK Bioscience Description and Business Overview
Table 112. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 114. SK Bioscience Recent Developments/Updates
Table 115. Walvax Biotechnology Company Information
Table 116. Walvax Biotechnology Description and Business Overview
Table 117. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 119. Walvax Biotechnology Recent Developments/Updates
Table 120. Eli Lilly Company Information
Table 121. Eli Lilly Description and Business Overview
Table 122. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 124. Eli Lilly Recent Developments/Updates
Table 125. Abera Company Information
Table 126. Abera Description and Business Overview
Table 127. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 129. Abera Recent Developments/Updates
Table 130. Sanofi Company Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Genentech Company Information
Table 136. Genentech Description and Business Overview
Table 137. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product
Table 139. Genentech Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Polyvalent Streptococcus Pneumococcal Vaccines Distributors List
Table 143. Polyvalent Streptococcus Pneumococcal Vaccines Customers List
Table 144. Polyvalent Streptococcus Pneumococcal Vaccines Market Trends
Table 145. Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers
Table 146. Polyvalent Streptococcus Pneumococcal Vaccines Market Challenges
Table 147. Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Polyvalent Streptococcus Pneumococcal Vaccines
Figure 2. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Type: 2024 & 2031
Figure 4. 9-Valent Product Picture
Figure 5. 13-Valent Product Picture
Figure 6. 23-Valent Product Picture
Figure 7. Others Product Picture
Figure 8. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Community Clinics
Figure 12. Public Health Agencies
Figure 13. Others
Figure 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size (2020-2031) & (US$ Million)
Figure 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (2020-2031) & (K Units)
Figure 17. Global Polyvalent Streptococcus Pneumococcal Vaccines Average Price (US$/Unit) & (2020-2031)
Figure 18. Polyvalent Streptococcus Pneumococcal Vaccines Report Years Considered
Figure 19. Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Manufacturers in 2024
Figure 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Polyvalent Streptococcus Pneumococcal Vaccines Players: Market Share by Revenue in Polyvalent Streptococcus Pneumococcal Vaccines in 2024
Figure 22. Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2020-2031)
Figure 25. North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2020-2031)
Figure 29. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2020-2031)
Figure 30. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2020-2031)
Figure 37. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2020-2031)
Figure 48. Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. U.A.E Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Polyvalent Streptococcus Pneumococcal Vaccines by Type (2020-2031)
Figure 58. Global Revenue Market Share of Polyvalent Streptococcus Pneumococcal Vaccines by Type (2020-2031)
Figure 59. Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Polyvalent Streptococcus Pneumococcal Vaccines by Application (2020-2031)
Figure 61. Global Revenue Market Share of Polyvalent Streptococcus Pneumococcal Vaccines by Application (2020-2031)
Figure 62. Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit) by Application (2020-2031)
Figure 63. Polyvalent Streptococcus Pneumococcal Vaccines Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
